Table 2.
Demographics and baseline characteristics of participants (N=109).
| Parameter | 4-week DMO (n=40) | 12-week DMO (n=40) | Combined DMO (n=80) | Usual care (n=29) |
| Age (years), mean (SE) | 58.8 (1.4) | 56.7 (1.8) | 57.8 (1.1) | 61.6 (1.7) |
| Female, n (%) | 21 (53) | 24 (60) | 45 (56) | 10 (35) |
| African American, n (%) | 11 (28) | 3 (8) | 14 (18) | 3 (10) |
| Caucasian, n (%) | 29 (73) | 24 (60) | 53 (66) | 19 (66) |
| Asian, n (%) | 0 (0) | 13 (33) | 13 (16) | 2 (7) |
| Hispanic ethnicity (includes all races), n (%) | 22 (55) | 15 (38) | 37 (46) | 14 (45) |
| Income ≤ US$20,000, n (%) | 23 (58) | 21 (53) | 44 (55) | 18 (62) |
| Education <high school, n (%) | 18 (45) | 6 (15) | 24 (30) | 10 (34) |
| Employed, n (%) | 18 (45) | 24 (60) | 42 (53) | 9 (31) |
| Weight (kg), mean (SE) | 91.5 (5.9) | 85.7 (3.4) | 88.6 (3.3) | 89.7 (4.7) |
| BMI (kg/m2), mean (SE) | 32.8 (1.4) | 30.7 (0.9) | 31.8 (0.9) | 31.3 (1.0) |
| Systolic BP (mm Hg), mean (SE) | 152.2 (1.6) | 146.5 (0.8)a | 149.3 (1.5)a | 155.4 (3.0) |
| Diastolic BP (mm Hg), mean (SE) | 90.5 (2.8) | 82.0 (5.1) | 86.2 (3.2) | 83.9 (2.9) |
| HbA1c (%), mean (SE) | 8.8 (0.3) | 8.5 (0.2) | 8.7 (0.2) | 8.3 (0.4) |
| FPG (mg/dL), mean (SE) | 174.2 (13.6) | 191.4 (16.2) | 182.8 (9.9) | 165.0 (8.5) |
| LDL-C (mg/dL), mean (SE) | 110.7 (5.3) | 107.1 (6.6) | 108.9 (3.9) | 99.1 (6.2) |
| HDL-C (mg/dL), mean (SE) | 47.8 (2.6) | 45.2 (1.5) | 46.5 (1.4) | 40.6 (2.5) |
| Triglycerides (mg/dL), mean (SE) | 211.2 (28.1) | 195.7 (17.3) | 203.4 (16.2) | 226.1 (36.2) |
| Total cholesterol (mg/dL), mean (SE) | 190.2 (6.5) | 175.3 (6.0) | 182.8 (4.5) | 174.4 (13.2) |
aDifference compared to usual care was statistically significant (P<.05).